Insecticides (India) Limited has scheduled a board meeting for January 30, 2026, to consider its third-quarter financial results and potential interim dividend declaration. The agrochemical company issued an official communication to stock exchanges on January 14, 2026, outlining the meeting agenda and regulatory compliance measures.

Board Meeting Details and Agenda

The board meeting will address two primary matters of significant importance to shareholders. The directors will review the company's unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, while also evaluating potential dividend distribution.

Financial Results Consideration

The board will consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. This comprehensive review will provide insights into the company's operational performance across both individual entity and group-wide metrics during the specified period.

Interim Dividend Evaluation

The directors will evaluate the declaration of an interim dividend for FY2026, though the final decision remains contingent upon the board's assessment. Should the board decide to proceed with dividend distribution, February 6, 2026, has been designated as the record date for determining shareholder eligibility.

Trading Window Restrictions

In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has implemented trading window restrictions for designated insiders. The trading window closure commenced on January 1, 2026, and will remain in effect until 48 hours after the declaration of the unaudited financial results. The company had previously communicated these restrictions through letter dated December 24, 2025.

Regulatory Compliance and Communication

The board meeting announcement fulfills the company's obligations under Regulation 29(1)(a) and 42 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. The official communication was addressed to both BSE Limited and National Stock Exchange of India Limited through their respective compliance platforms, ensuring transparent communication with all stakeholders. The information has also been uploaded on the company's website at www.insecticidesindia.com .

Insecticides (India) Limited has received regulatory approval for a significant internal restructuring of its promoter shareholding. The Securities and Exchange Board of India (SEBI) has granted an exemption to the company's promoter group, allowing four family trusts to acquire a 67.65% stake without triggering mandatory open offer requirements.

SEBI Exemption Details

SEBI has granted the exemption under Regulation 11(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This exemption allows the proposed acquirers to bypass the requirements of Regulation 3(1) and Regulation 4 of the takeover regulations.

Acquiring Family Trusts

Four family trusts have been designated as the proposed acquirers in this transaction:

1. Sanskriti Family Trust
2. Akshay Family Trust
3. EJ Private Trust
4. KBZ Private Trust

All trusts are irrevocable, discretionary, private trusts settled under the Indian Trusts Act, 1882.

Share Transfer Structure

The proposed acquisition involves the transfer of 1,96,83,052 shares, representing 67.65% of the company's total share capital, from six promoter family members to the four trusts.

Transaction Rationale and Compliance

The proposed acquisition is being executed as a gift arrangement without monetary consideration, representing a private family arrangement for succession planning and internal reorganization within the promoter family. The transaction ensures compliance with minimum public shareholding requirements, with public shareholding remaining unchanged at 27.70%.

This exemption from SEBI facilitates the succession planning within the promoter family of Insecticides (India) Limited, allowing for a smooth transfer of a significant stake to family trusts without triggering an open offer.